MedTrace Logo

Safety and Feasibility of High-intensity Interval Training Program in CF Patients

NCT04888767 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2023-09-15

No results posted yet for this study

Summary

This study compare an usual training program (in continuous endurance) with an ITHI program over a period of 3 weeks, in France. The aim is to evaluate the safety and feasibility of this type of program in CF adults, and also more specifically, in subgroups:

patients divided according to the severity of their FEV1 ; patients treated with modulating CFTR canal therapy ; diabetic patients on insulin ; undernourished patients.

Conditions

Interventions

OTHER

Interval Training Hight Intensity Program

* Rehabilitation stay in hospitalization with 18 days of training sessions * Training on an ergometer * Sessions supervised by an Adapted Physical Activities (APA) teacher or a physiotherapist * Control group: 5 times / week; continuous work 20 to 30 min; around the 1st aerobic ventilation threshold * Intervention group: 2 times / week: maintenance sessions + 3 times / week: IHTI sessions - alternating 30s work / 30s rest repeated 6 times; at 60% of the maximum heart rate at the 1st session then increase as fast and large as possible

Sponsors & Collaborators

  • Lille Catholic University

    collaborator OTHER

  • Fondation Ildys

    lead OTHER

Principal Investigators

  • Sophie Ramel, MD · Fondation Ildys

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2023-09-13
Completion
2023-09-13

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04888767 on ClinicalTrials.gov